China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Statistics

Total Valuation

SXTC has a market cap or net worth of $2.32 million. The enterprise value is -$17.78 million.

Market Cap	2.32M
Enterprise Value	-17.78M

Important Dates

The last earnings date was Monday, August 19, 2019, before market open.

Earnings Date	Aug 19, 2019
Ex-Dividend Date	n/a

Share Statistics

SXTC has 933,522 shares outstanding.

Current Share Class	933,522
Shares Outstanding	933,522
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	29.28%
Owned by Institutions (%)	0.26%
Float	660,203

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.64
Forward PS	n/a
PB Ratio	0.10
P/TBV Ratio	0.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.37, with a Debt / Equity ratio of 0.06.

Current Ratio	4.37
Quick Ratio	4.04
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.25

Financial Efficiency

Return on equity (ROE) is -50.30% and return on invested capital (ROIC) is -6,457.21%.

Return on Equity (ROE)	-50.30%
Return on Assets (ROA)	-18.27%
Return on Invested Capital (ROIC)	-6,457.21%
Return on Capital Employed (ROCE)	-41.10%
Weighted Average Cost of Capital (WACC)	24.21%
Revenue Per Employee	$20,506
Profits Per Employee	-$118,265
Employee Count	75
Asset Turnover	0.05
Inventory Turnover	0.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.46% in the last 52 weeks. The beta is 1.68, so SXTC's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-99.46%
50-Day Moving Average	127.17
200-Day Moving Average	214.59
Relative Strength Index (RSI)	24.07
Average Volume (20 Days)	689,887

Short Selling Information

Short Interest	3.41M
Short Previous Month	173,618
Short % of Shares Out	2.66%
Short % of Float	n/a
Short Ratio (days to cover)	0.18

Income Statement

In the last 12 months, SXTC had revenue of $1.54 million and -$8.87 million in losses. Loss per share was -$22.46.

Revenue	1.54M
Gross Profit	334,395
Operating Income	-8.38M
Pretax Income	-8.87M
Net Income	-8.87M
EBITDA	-8.34M
EBIT	-8.38M
Loss Per Share	-$22.46

Balance Sheet

The company has $21.31 million in cash and $1.20 million in debt, with a net cash position of $20.10 million or $21.54 per share.

Cash & Cash Equivalents	21.31M
Total Debt	1.20M
Net Cash	20.10M
Net Cash Per Share	$21.54
Equity (Book Value)	20.23M
Book Value Per Share	26.16
Working Capital	20.08M

Cash Flow

In the last 12 months, operating cash flow was -$2.74 million and capital expenditures -$2,023, giving a free cash flow of -$2.74 million.

Operating Cash Flow	-2.74M
Capital Expenditures	-2,023
Free Cash Flow	-2.74M
FCF Per Share	-$2.94

Margins

Gross Margin	21.74%
Operating Margin	-544.94%
Pretax Margin	-576.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SXTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-381.59%
FCF Yield	-117.99%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 3, 2026. It was a reverse split with a ratio of 1:150.

Last Split Date	Feb 3, 2026
Split Type	Reverse
Split Ratio	1:150

Scores

SXTC has an Altman Z-Score of 4.61 and a Piotroski F-Score of 3.

Altman Z-Score	4.61
Piotroski F-Score	3